You are here

SUBSCRIBERS
A SMART LOOK AT INVESTING

Bright future for tech stocks in post-Covid world

It is doubtful that companies will stop their digital transformation simply because the threat of Covid-19 has been removed

BT_20201125_CHONG_4340299.jpg
Pfizer's vaccine candidate also poses a significant logistical challenge since it needs to be transported and stored at an extremely cold temperature of minus 70 degrees celsius.

ON NOV 9, 2020, Pfizer announced a wonderful development for mankind. Trial results from the pharmaceutical giant's Covid-19 vaccine candidate, developed together with Bio NTech, showed that it could be 90 per cent effective in preventing infection.

A week later, Moderna revealed that its...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes